璋利國際(01693.HK)盈喜:預期年度淨利約1190萬令吉
格隆匯6月16日丨璋利國際(01693.HK)公吿,集團預計截至2023年3月31日止十二個月將錄得未經審核公司權益擁有人應占溢利大約為1190萬令吉,與截至2022年3月31日止十八個月期間公司權益擁有人應占虧損為5650萬令吉相比。
報吿期間淨利潤的改善主要是由於(其中包括):(i)集團成功獲得兩項主要項目的延長施工期,致使應付給客户的預期違約賠償金減少;(ii)較低的金融資產和合同資產減值虧損;(iii)在馬來西亞上訴法院駁回客户A針對有利於集團的禁令的上訴後,撥回銀行履約保證金撥備;和(iv)於相應期間出售附屬公司虧損約2570萬令吉,而報吿期間並無此虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.